Pharmavise Corporation, founded in 2013, provides regulatory compliance solutions for life sciences organizations. The company's core business involves transforming compliance into a strategic advantage through digitally driven, continuous compliance people and process solutions. Its team includes seasoned professionals such as scientists, researchers, and regulatory experts.
The company operates across the pharmaceutical, medical device, biotechnology, and healthcare sectors, with a worldwide geographic presence. Pharmavise's technical domains span regulatory compliance, quality systems, computer system validation, and clinical and manufacturing audits. Its service offerings include FDA Warning Letter Remediation, regulatory and quality system compliance, clinical and manufacturing audits, and computer system validation.
Pharmavise has supported over 20 technical transfers, 30 product launches, and 11 FDA remediations, reflecting its operational track record in the life sciences compliance space.
